BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34348686)

  • 1. Fertility sparing surgery in malignant ovarian Germ cell tumor (MOGCT): 15 years experiences.
    Zamani N; Rezaei Poor M; Ghasemian Dizajmehr S; Alizadeh S; Modares Gilani M
    BMC Womens Health; 2021 Aug; 21(1):282. PubMed ID: 34348686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors.
    Zhang N; Chen R; Hua K; Zhang Y
    J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive function assessment after surgery plus chemotherapy for germ cell ovarian tumors (MOGCT): novel clues deriving from the field of fertility preservation.
    Ottolina J; Mangili G; Sigismondi C; Vanni VS; Viganò P; Candiani M
    Gynecol Endocrinol; 2014 Nov; 30(11):778-80. PubMed ID: 25034573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.
    Tamauchi S; Kajiyama H; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Kikkawa F
    Am J Obstet Gynecol; 2018 Oct; 219(4):385.e1-385.e7. PubMed ID: 30086295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
    Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
    Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
    Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
    Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
    Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.
    Vasanth A; Patel SM; Arora R; Parekh CD; Dave P; Patel BM; Vemanamandhi P
    J Gynecol Oncol; 2024 Mar; 35(2):e19. PubMed ID: 37921603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
    Weinberg LE; Lurain JR; Singh DK; Schink JC
    Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.
    Ayhan A; Tunç M; Akıllı H; Haberal N; Haberal A
    Int J Gynaecol Obstet; 2024 Mar; 164(3):1074-1079. PubMed ID: 37737565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".
    Solheim O; Tropé CG; Rokkones E; Kærn J; Paulsen T; Salvesen HB; Hagen B; Vereide AB; Fosså SD
    Gynecol Oncol; 2015 Feb; 136(2):224-9. PubMed ID: 25511159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.